Literature DB >> 33557089

Comprehensive Epstein-Barr Virus Transcriptome by RNA-Sequencing in Angioimmunoblastic T Cell Lymphoma (AITL) and Other Lymphomas.

Nader Bayda1,2, Valentin Tilloy3, Alain Chaunavel4, Racha Bahri1, Mohamad Adnan Halabi1, Jean Feuillard5, Arnaud Jaccard6, Sylvie Ranger-Rogez1,7.   

Abstract

The Epstein-Barr virus (EBV) is associated with angioimmunoblastic T cell lymphoma (AITL) in more than 80% of cases. Few studies have focused on this association and it is not clear now what role the virus plays in this pathology. We used next-generation sequencing (NGS) to study EBV transcriptome in 14 AITLs compared to 21 other lymphoma samples and 11 cell lines including 4 lymphoblastoid cell lines (LCLs). Viral transcripts were recovered using capture probes and sequencing was performed on Illumina. Bam-HI A rightward transcripts (BARTs) were the most latency transcripts expressed in AITLs, suggesting they may play a role in this pathology. Thus, BARTs, already described as highly expressed in carcinoma cells, are also very present in AITLs and other lymphomas. They were poorly expressed in cell lines other than LCLs. AITLs showed a latency IIc, with BNLF2a gene expression. For most AITLs, BCRF1, which encodes a homologous protein of human interleukin 10, vIL-10, was in addition expressed. This co-expression can contribute to immune escape and survival of infected cells. Considering these results, it can be assumed that EBV plays a pathogenic role in AITLs.

Entities:  

Keywords:  AITL; EBV; Epstein-Barr virus; NGS; angioimmunoblastic T cell lymphoma; lymphoma; next-generation sequencing; transcriptome; transcripts

Year:  2021        PMID: 33557089      PMCID: PMC7913808          DOI: 10.3390/cancers13040610

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  78 in total

1.  Epstein-Barr virus RNA in Burkitt tumor tissue.

Authors:  T Dambaugh; F K Nkrumah; R J Biggar; E Kieff
Journal:  Cell       Date:  1979-02       Impact factor: 41.582

2.  Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus.

Authors:  G Klein; L Dombos; B Gothoskar
Journal:  Int J Cancer       Date:  1972-07-15       Impact factor: 7.396

3.  Sequence analysis of Raji Epstein-Barr virus DNA.

Authors:  G Hatfull; A T Bankier; B G Barrell; P J Farrell
Journal:  Virology       Date:  1988-06       Impact factor: 3.616

4.  Detection of Epstein-Barr virus strain variants in lymphoblastoid cell lines 'spontaneously' derived from patients with rheumatoid arthritis, infectious mononucleosis and normal controls.

Authors:  T B Sculley; D J Moss; R A Hazelton; J H Pope
Journal:  J Gen Virol       Date:  1987-08       Impact factor: 3.891

5.  Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas.

Authors:  Jia Yun Zhu; Thorsten Pfuhl; Natalie Motsch; Stephanie Barth; John Nicholls; Friedrich Grässer; Gunter Meister
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

6.  Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines.

Authors:  A G Bird; S M McLachlan; S Britton
Journal:  Nature       Date:  1981-01-22       Impact factor: 49.962

7.  Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line.

Authors:  Y Hinuma; M Konn; J Yamaguchi; D J Wudarski; J R Blakeslee; J T Grace
Journal:  J Virol       Date:  1967-10       Impact factor: 5.103

8.  EBV gene expression in an NPC-related tumour.

Authors:  M M Hitt; M J Allday; T Hara; L Karran; M D Jones; P Busson; T Tursz; I Ernberg; B E Griffin
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

9.  Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis.

Authors:  Markus Altmann; Wolfgang Hammerschmidt
Journal:  PLoS Biol       Date:  2005-11-15       Impact factor: 8.029

10.  A Viral microRNA Cluster Regulates the Expression of PTEN, p27 and of a bcl-2 Homolog.

Authors:  Katharina Bernhardt; Janina Haar; Ming-Han Tsai; Remy Poirey; Regina Feederle; Henri-Jacques Delecluse
Journal:  PLoS Pathog       Date:  2016-01-22       Impact factor: 6.823

View more
  4 in total

1.  Epstein-Barr Virus (EBV) Is Mostly Latent and Clonal in Angioimmunoblastic T Cell Lymphoma (AITL).

Authors:  Racha Bahri; François Boyer; Mohamad Adnan Halabi; Alain Chaunavel; Jean Feuillard; Arnaud Jaccard; Sylvie Ranger-Rogez
Journal:  Cancers (Basel)       Date:  2022-06-12       Impact factor: 6.575

Review 2.  The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy.

Authors:  Géraldine Schlecht-Louf; Claire Deback; Françoise Bachelerie
Journal:  Cancers (Basel)       Date:  2022-02-08       Impact factor: 6.639

3.  Alternative c-MYC mRNA Transcripts as an Additional Tool for c-Myc2 and c-MycS Production in BL60 Tumors.

Authors:  Dina Ibrahim; Léa Prévaud; Nathalie Faumont; Danielle Troutaud; Jean Feuillard; Mona Diab-Assaf; Ahmad Oulmouden
Journal:  Biomolecules       Date:  2022-06-16

4.  Lymphomas associated with Epstein-Barr virus infection in 2020: Results from a large, unselected case series in France.

Authors:  Marie Donzel; Maxime Bonjour; Jean-Damien Combes; Florence Broussais; Pierre Sesques; Alexandra Traverse-Glehen; Catherine de Martel
Journal:  EClinicalMedicine       Date:  2022-10-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.